Global Implantable Cardioverter Defibrillators (ICD) Market Outlook 2018-2022, with Abbott, Biotronik, Boston Scientific and Medtronic Dominating - ResearchAndMarkets.com

DUBLIN--()--The "Global Implantable Cardioverter Defibrillators (ICD) Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The implantable cardioverter defibrillators market will register a CAGR of almost 2% by 2022.

Technological advances to drive growth in the market

Technological advances such as the introduction of quadripolar lead devices, improvements in patient monitoring to avoid needless shocks, and development of MRI safe ICDs have significantly improved the reliability and effectiveness of ICDs.

Increasing prevalence of cardiac arrhythmias

Prevalence of cardiac arrhythmias is steadily increasing. With the rise in cardiac disorders the demand for implantable cardioverter defibrillators will also increase.

Device limitations and complications

ICDs have been associated with many undesirable effects such as lead failures, deterioration in the quality of life, repeated in appropriate shocks, and premature battery complications.

Key Players

  • Abbott
  • Biotronik
  • Boston Scientific
  • Medtronic

Topics Covered

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

PART 06: FIVE FORCES ANALYSIS

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Regular ICD
  • CRT-D
  • S-ICD
  • Market opportunity by product

PART 08: MARKET SEGMENTATION BY END-USER

  • Hospitals and clinics
  • ASCs

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • ICD market in Americas
  • ICD market in EMEA
  • ICD market in APAC
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

PART 13: MARKET TRENDS

  • Technological advances
  • Increasing popularity of remote monitoring and follow-up of ICDs

PART 14: VENDOR LANDSCAPE

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • Biotronik
  • Boston Scientific
  • Medtronic

For more information about this report visit https://www.researchandmarkets.com/research/xx9dg2/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Devices

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Devices